Comparable stake leader
Qiming U.S. Healthcare Fund III, L.P.
SEC ownership of Satellos Bioscience Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001421642.
Disclosed value leader
Qiming U.S. Healthcare Fund III, L.P.
Comparable rows
2/28
Latest evidence
30 Jun 2026
- Public ticker
- MSLE on Nasdaq
- Parsed ownership sources
-
13D/G and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Qiming U.S. Healthcare Fund III, L.P.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
2 of 28
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Qiming U.S. Healthcare Fund III, L.P.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001421642
- Issuer location
- Markham
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Satellos Bioscience Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Qiming U.S. Healthcare Fu...
Disclosed value leader
Qiming U.S. Healthcare Fu...
Comparable rows
2/28
Latest evidence
30 Jun 2026
13D/G
13F
Lead comparable stake: 8.3%
26 rows are not safely comparable across share classes.
13D/G row: Qiming U.S. Healthcare Fund III, L.P.
Showing 1-8 of 28 holder rows.
Quick read
Qiming U.S. Healthcare Fund III, L.P. leads the comparable SEC ownership view at 8.3%.
2 of 28 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Qiming U.S. Healthcare Fund III, L.P.'s linked filing trail.
Comparable ownership
Top 2
Qiming U.S. Healthcare Fund III, ...
8.3%
Brian Matthew Bloom
7.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 28 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Qiming U.S. Healthcare Fund III, L.P. |
13D/G
|
8.3%
Reported 13D/G
· 31 Mar 2026
|
$9,713,658
1,725,247 shares
|
$0 | 31 Mar 2026 |
| Brian Matthew Bloom |
13D/G
|
7.4%
Reported 13D/G
· 06 Feb 2026
|
$6,381,048
1,133,401 shares
|
$0 | 06 Feb 2026 |
| FRANKLIN TEMPLETON INC |
13F
Company
|
—
denominator unverified
|
$7,227,934
938,666 shares
|
— | 30 Jun 2026 |
| Siren, L.L.C. |
13F
Individual
|
—
denominator unverified
|
$6,935,875
892,074 shares
|
— | 30 Jun 2026 |
| Vivo Capital, LLC |
13F
Company
|
—
denominator unverified
|
$6,326,253
813,666 shares
|
— | 30 Jun 2026 |
| Point72 Asset Management, L.P. |
13F
Company
|
—
denominator unverified
|
$5,307,993
682,700 shares
|
— | 30 Jun 2026 |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
Company
|
—
denominator unverified
|
$5,073,887
652,590 shares
|
— | 30 Jun 2026 |
| Woodline Partners LP |
13F
Company
|
—
denominator unverified
|
$3,890,859
500,432 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 24 Oct 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Recent insider transactions for Satellos Bioscience Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.